Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-04-14

Clinical Trial Update: Low-Dose Naltrexone and Acetaminophen Combination and Sumatriptan in the Acute Treatment of Migraine With Nausea [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial evaluating a low-dose naltrexone and acetaminophen combination with sumatriptan for acute treatment of migraine with and without aura…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Low-dose naltrexone + acetaminophen combination with sumatriptan

Snippet

Sponsor: Allodynic Therapeutics, Inc | Conditions: Migraine With and Without Aura | Phase 2, Phase 3 | Status: COMPLETED